TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 4 | 1 | -2 | -6 | -9 | 12 | -15 | -3 |
| P | %wins | 100 | 50 | 0 | 50 | 50 | 25 | 46 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/15 16:26 | 11/10/15 | FOLD | Amicus Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | NJ | D | P | 103 | 10.27 | 27 | 10 | New | 10 | D | 409 | 80 | -5 | -35 | -21 | 55 | 36 | 8 | 1 | 0 | -5 | -46 | -34 | -21 | |
11/8/12 16:21 | 11/7/12 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | MA | D | P | 46 | 45.50 | 33 | 1 | New | 1 | D | 30 | 24 | -29 | -12 | -19 | -15 | -9 | 1 | 1 | -5 | -13 | 3 | 79 | 36 | |
2/4/04 14:27 | 2/3/04 | MRK | Merck & Co Inc | NJ | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | NJ | O | PU.S.Hum | P | 120 | 48.00 | 33 | 3 | 25 | 12 | M | -9 | -6 | -4 | 11 | 9 | 6 | 6 | 0 | 1 | 0 | -1 | -1 | -6 | -39 |
10/31/03 14:25 | 10/30/03 | MRK | Merck & Co Inc | NJ | Health | Drug | Pharmaceutical Preparations | McGlynn Margaret G | NJ | O | PU.S.Hum | P | 112 | 44.70 | 33 | 3 | 27 | 12 | M | -24 | -12 | -21 | -14 | -16 | -11 | -10 | -2 | 1 | -1 | -4 | 10 | 10 | -34 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |